0001209191-17-031672.txt : 20170511 0001209191-17-031672.hdr.sgml : 20170511 20170511200353 ACCESSION NUMBER: 0001209191-17-031672 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170509 FILED AS OF DATE: 20170511 DATE AS OF CHANGE: 20170511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1217 BUSINESS ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-697-3939 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zanganeh Maky CENTRAL INDEX KEY: 0001507650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 17836040 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-09 0 0001625101 Pulse Biosciences, Inc. PLSE 0001507650 Zanganeh Maky 849 MITTEN ROAD, SUITE 104 BURLINGAME CA 94010 1 0 0 0 Common Stock 2017-05-11 4 P 0 15000 20.836 A 278935 D Common Stock 2017-05-09 4 P 0 33760 20.157 A 80474 I Dependent Minor Common Stock 2017-05-10 4 P 0 5000 21.709 A 85474 I Dependent Minor This is the weighted average purchase price of the shares, which ranged from $20.66 to $20.945 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $19.885 to $20.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $20.99 to $21.921 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Brian Dow, as Attorney-in-Fact for Maky Zanganeh 2017-05-11